{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:14:44Z","timestamp":1790763284574,"version":"4.1.0"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,20]]},"DOI":"10.4103\/0366-6999.220313","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T10:36:33Z","timestamp":1513852593000},"page":"2978-2990","source":"Crossref","is-referenced-by-count":60,"title":["Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease"],"prefix":"10.1097","volume":"130","author":[{"given":"Xi-Lin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pi\u00f1a-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Xi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13024-017-0190-z","article-title":"Targeting psychologic stress signaling pathways in Alzheimer's disease","volume":"12","author":"Futch","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","article-title":"Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk","volume":"12","author":"Efthymiou","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-017-0172-1","article-title":"Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: Characterization and therapeutic potency","volume":"12","author":"Agadjanyan","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","article-title":"Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture","volume":"12","author":"Miyamoto","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stemcr.2017.06.005","article-title":"MAPT genetic variation and neuronal maturity alter isoform expression affecting axonal transport in iPSC-derived dopamine neurons","volume":"9","author":"Beevers","year":"2017","journal-title":"Stem Cell Reports"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pbio.1000034","article-title":"Structural polymorphism of 441-residue tau at single residue resolution","volume":"7","author":"Mukrasch","year":"2009","journal-title":"PLoS Biol"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","article-title":"Glial contributions to neurodegeneration in tauopathies","volume":"12","author":"Leyns","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1523\/JNEUROSCI.2569-11.2011","article-title":"In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice","volume":"31","author":"Yamada","year":"2011","journal-title":"J Neurosci"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"12192","DOI":"10.1074\/jbc.M117.784702","article-title":"Axodendritic sorting and pathological missorting of tau are isoform-specific and determined by axon initial segment architecture","volume":"292","author":"Zempel","year":"2017","journal-title":"J Biol Chem"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: Implications for Alzheimer's disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem Int"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: The therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol Med"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1074\/jbc.275.8.5535","article-title":"Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease","volume":"275","author":"Gong","year":"2000","journal-title":"J Biol Chem"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1083\/jcb.201305098","article-title":"Cell biology in neuroscience: Cellular and molecular mechanisms underlying axon formation, growth, and branching","volume":"202","author":"Lewis","year":"2013","journal-title":"J Cell Biol"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.neurobiolaging.2013.03.015","article-title":"Tau phosphorylation affects its axonal transport and degradation","volume":"34","author":"Rodr\u00edguez-Mart\u00edn","year":"2013","journal-title":"Neurobiol Aging"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","volume":"8","author":"Violet","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-016-0139-7","article-title":"Kim DY 3D culture models of Alzheimer's disease: A road map to a \u201ccure-in-a-dish\u201d","volume":"11","author":"Choi","year":"2016","journal-title":"Mol Neurodegener"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-015-0025-8","article-title":"Regulation of human MAPT gene expression","volume":"10","author":"Caillet-Boudin","year":"2015","journal-title":"Mol Neurodegener"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.3233\/JAD-2012-129031","article-title":"Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration","volume":"33","author":"Wang","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13365","article-title":"Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: Facts and hypotheses","volume":"136","author":"Wilkaniec","year":"2016","journal-title":"J Neurochem"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J Neurochem"},{"key":"R25-11-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"R26-11-20210129","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-11-20210129","doi-asserted-by":"crossref","first-page":"34873","DOI":"10.1074\/jbc.M405131200","article-title":"Promotion of hyperphosphorylation by frontotemporal dementia tau mutations","volume":"279","author":"Alonso Adel","year":"2004","journal-title":"J Biol Chem"},{"key":"R28-11-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: The story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"R29-11-20210129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"R30-11-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI29715","article-title":"The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins","volume":"117","author":"Dickey","year":"2007","journal-title":"J Clin Invest"},{"key":"R31-11-20210129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"key":"R32-11-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/hmg\/ddt402","article-title":"Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance","volume":"23","author":"Cook","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R33-11-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncomms1255","article-title":"The acetylation of tau inhibits its function and promotes pathological tau aggregation","volume":"2","author":"Cohen","year":"2011","journal-title":"Nat Commun"},{"key":"R34-11-20210129","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nat Med"},{"key":"R35-11-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-016-0109-0","article-title":"Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment","volume":"11","author":"Sohn","year":"2016","journal-title":"Mol Neurodegener"},{"key":"R36-11-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(02)02228-7","article-title":"Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease","volume":"512","author":"Liu","year":"2002","journal-title":"FEBS Lett"},{"key":"R37-11-20210129","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1073\/pnas.0400348101","article-title":"O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease","volume":"101","author":"Liu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-11-20210129","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-glcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"R39-11-20210129","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1042\/BST0380955","article-title":"Proteolytic processing of tau","volume":"38","author":"Wang","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"R40-11-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J Clin Invest"},{"key":"R41-11-20210129","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1523\/JNEUROSCI.1988-04.2004","article-title":"Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease","volume":"24","author":"Horowitz","year":"2004","journal-title":"J Neurosci"},{"key":"R42-11-20210129","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm.3700","article-title":"Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease","volume":"20","author":"Zhang","year":"2014","journal-title":"Nat Med"},{"key":"R43-11-20210129","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm.4199","article-title":"Caspase-2 cleavage of tau reversibly impairs memory","volume":"22","author":"Zhao","year":"2016","journal-title":"Nat Med"},{"key":"R44-11-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"R45-11-20210129","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments","volume":"38","author":"Schneider","year":"1999","journal-title":"Biochemistry"},{"key":"R46-11-20210129","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1523\/JNEUROSCI.2824-07.2008","article-title":"The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous tau in inducible mouse models of tauopathy","volume":"28","author":"Mocanu","year":"2008","journal-title":"J Neurosci"},{"key":"R47-11-20210129","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R48-11-20210129","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","article-title":"Caspase activation precedes and leads to tangles","volume":"464","author":"de Calignon","year":"2010","journal-title":"Nature"},{"key":"R49-11-20210129","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00401-012-0987-3","article-title":"Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human tau","volume":"123","author":"Van der Jeugd","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R50-11-20210129","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1093\/hmg\/ddq363","article-title":"Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies","volume":"19","author":"Falzone","year":"2010","journal-title":"Hum Mol Genet"},{"key":"R51-11-20210129","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuron.2012.06.026","article-title":"Tau promotes neurodegeneration via DRP1 mislocalization in vivo","volume":"75","author":"DuBoff","year":"2012","journal-title":"Neuron"},{"key":"R52-11-20210129","doi-asserted-by":"crossref","first-page":"619.e25","DOI":"10.1016\/j.neurobiolaging.2011.02.007","article-title":"Truncated tau and a\u03b2 cooperatively impair mitochondria in primary neurons","volume":"33","author":"Quintanilla","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R53-11-20210129","doi-asserted-by":"crossref","first-page":"e44996","DOI":"10.1371\/journal.pone.0044996","article-title":"Model hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain","volume":"7","author":"Furgerson","year":"2012","journal-title":"PLoS One"},{"key":"R54-11-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2121-10-81","article-title":"The proline-rich domain of tau plays a role in interactions with actin","volume":"10","author":"He","year":"2009","journal-title":"BMC Cell Biol"},{"key":"R55-11-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature13163","article-title":"REST and stress resistance in ageing and Alzheimer's disease","volume":"507","author":"Lu","year":"2014","journal-title":"Nature"},{"key":"R56-11-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-011-0836-9","article-title":"Peroxisomal alterations in Alzheimer's disease","volume":"122","author":"Kou","year":"2011","journal-title":"Acta Neuropathol"},{"key":"R57-11-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/156720509787313970","article-title":"DNA damage and repair in Alzheimer's disease","volume":"6","author":"Copped\u00e8","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"R58-11-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"key":"R59-11-20210129","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/brain\/awv236","article-title":"The preclinical phase of the pathological process underlying sporadic Alzheimer's disease","volume":"138","author":"Braak","year":"2015","journal-title":"Brain"},{"key":"R60-11-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2016.13","article-title":"A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration","volume":"17","author":"Walsh","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"R61-11-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-015-1507-z","article-title":"Propagation of tau pathology: Hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies","volume":"131","author":"Lewis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R62-11-20210129","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.1222951","article-title":"Cell biology. A unifying role for prions in neurodegenerative diseases","volume":"336","author":"Prusiner","year":"2012","journal-title":"Science"},{"key":"R63-11-20210129","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"R64-11-20210129","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","article-title":"Propagation of tau misfolding from the outside to the inside of a cell","volume":"284","author":"Frost","year":"2009","journal-title":"J Biol Chem"},{"key":"R65-11-20210129","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"key":"R66-11-20210129","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat Cell Biol"},{"key":"R67-11-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer's disease","volume":"73","author":"de Calignon","year":"2012","journal-title":"Neuron"},{"key":"R68-11-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00401-014-1254-6","article-title":"A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: The pattern of spread is determined by connectivity, not proximity","volume":"127","author":"Ahmed","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R69-11-20210129","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","article-title":"Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy","volume":"33","author":"Iba","year":"2013","journal-title":"J Neurosci"},{"key":"R70-11-20210129","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-015-1413-4","article-title":"Templated misfolding of tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in tau transgenic mice","volume":"129","author":"Stancu","year":"2015","journal-title":"Acta Neuropathol"},{"key":"R71-11-20210129","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R72-11-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","article-title":"Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains","volume":"129","author":"Boluda","year":"2015","journal-title":"Acta Neuropathol"},{"key":"R73-11-20210129","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat Neurosci"},{"key":"R74-11-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-015-1458-4","article-title":"Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections","volume":"130","author":"Iba","year":"2015","journal-title":"Acta Neuropathol"},{"key":"R75-11-20210129","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"key":"R76-11-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","article-title":"The release and trans-synaptic transmission of Tau via exosomes","volume":"12","author":"Wang","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R77-11-20210129","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","article-title":"Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons","volume":"288","author":"Wu","year":"2013","journal-title":"J Biol Chem"},{"key":"R78-11-20210129","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","article-title":"Loss of bin1 promotes the propagation of tau pathology","volume":"17","author":"Calafate","year":"2016","journal-title":"Cell Rep"},{"key":"R79-11-20210129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat Neurosci"},{"key":"R80-11-20210129","doi-asserted-by":"crossref","first-page":"14893","DOI":"10.1074\/jbc.M115.652693","article-title":"Tau trimers are the minimal propagation unit spontaneously internalized to seed intracellular aggregation","volume":"290","author":"Mirbaha","year":"2015","journal-title":"J Biol Chem"},{"key":"R81-11-20210129","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","article-title":"Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells","volume":"35","author":"Usenovic","year":"2015","journal-title":"J Neurosci"},{"key":"R82-11-20210129","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1074\/jbc.M113.515445","article-title":"Extracellular monomeric tau protein is sufficient to initiate the spread of tau protein pathology","volume":"289","author":"Michel","year":"2014","journal-title":"J Biol Chem"},{"key":"R83-11-20210129","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1523\/JNEUROSCI.3542-15.2016","article-title":"Short fibrils constitute the major species of seed-competent tau in the brains of mice transgenic for human P301S tau","volume":"36","author":"Jackson","year":"2016","journal-title":"J Neurosci"},{"key":"R84-11-20210129","doi-asserted-by":"crossref","first-page":"8490","DOI":"10.1038\/ncomms9490","article-title":"Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain","volume":"6","author":"Takeda","year":"2015","journal-title":"Nat Commun"},{"key":"R85-11-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00401-015-1525-x","article-title":"Heterotypic seeding of tau fibrillization by pre-aggregated abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo","volume":"131","author":"Vasconcelos","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R86-11-20210129","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2013.66","article-title":"Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain","volume":"21","author":"Caillierez","year":"2013","journal-title":"Mol Ther"},{"key":"R87-11-20210129","doi-asserted-by":"crossref","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","article-title":"Seeded aggregation and toxicity of \u03b1-synuclein and tau: Cellular models of neurodegenerative diseases","volume":"285","author":"Nonaka","year":"2010","journal-title":"J Biol Chem"},{"key":"R88-11-20210129","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1021\/bi2004685","article-title":"Variations in filament conformation dictate seeding barrier between three- and four-repeat tau","volume":"50","author":"Dinkel","year":"2011","journal-title":"Biochemistry"},{"key":"R89-11-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/2051-5960-2-73","article-title":"Characterization of tau oligomeric seeds in progressive supranuclear palsy","volume":"2","author":"Gerson","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"R90-11-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"R92-11-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00401-010-0794-7","article-title":"Tau pathology in children and young adults: Can you still be unconditionally baptist?","volume":"121","author":"Duyckaerts","year":"2011","journal-title":"Acta Neuropathol"},{"key":"R93-11-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/WCO.0b013e32835a30f4","article-title":"Origins of Alzheimer's disease: Reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement","volume":"25","author":"Musiek","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"R94-11-20210129","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/brain\/awu176","article-title":"A data-driven model of biomarker changes in sporadic Alzheimer's disease","volume":"137","author":"Young","year":"2014","journal-title":"Brain"},{"key":"R95-11-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"R96-11-20210129","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","volume":"85","author":"Palmqvist","year":"2015","journal-title":"Neurology"},{"key":"R97-11-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","article-title":"Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: A sandwich ELISA with a synthetic phosphopeptide for standardization","volume":"285","author":"Vanmechelen","year":"2000","journal-title":"Neurosci Lett"},{"key":"R98-11-20210129","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer's disease neuroimaging initiative: A review of papers published since its inception","volume":"9","author":"Weiner","year":"2013","journal-title":"Alzheimers Dement"},{"key":"R99-11-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1373\/clinchem.2006.081679","article-title":"Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid beta(42) and tau proteins","volume":"53","author":"Reijn","year":"2007","journal-title":"Clin Chem"},{"key":"R100-11-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nm.3810","article-title":"Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding","volume":"21","author":"Blennow","year":"2015","journal-title":"Nat Med"},{"key":"R101-11-20210129","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"R102-11-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.resuscitation.2012.07.027","article-title":"Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study","volume":"84","author":"Randall","year":"2013","journal-title":"Resuscitation"},{"key":"R103-11-20210129","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bios.2016.10.077","article-title":"Detection of the tau protein in human serum by a sensitive four-electrode electrochemical biosensor","volume":"92","author":"Wang","year":"2017","journal-title":"Biosens Bioelectron"},{"key":"R104-11-20210129","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jalz.2014.09.003","article-title":"Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?","volume":"11","author":"Lehmann","year":"2015","journal-title":"Alzheimers Dement"},{"key":"R105-11-20210129","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jalz.2015.05.003","article-title":"The Alzheimer's disease neuroimaging initiative 2 biomarker core: A review of progress and plans","volume":"11","author":"Kang","year":"2015","journal-title":"Alzheimers Dement"},{"key":"R106-11-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","article-title":"Tau PET imaging: Present and future directions","volume":"12","author":"Saint-Aubert","year":"2017","journal-title":"Mol Neurodegener"},{"key":"R107-11-20210129","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N Engl J Med"},{"key":"R108-11-20210129","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: A novel in vivo tau imaging ligand for Alzheimer's disease","volume":"134","author":"Fodero-Tavoletti","year":"2011","journal-title":"Brain"},{"key":"R109-11-20210129","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/brain\/awu064","article-title":"Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET","volume":"137","author":"Okamura","year":"2014","journal-title":"Brain"},{"key":"R110-11-20210129","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s00259-015-3035-4","article-title":"[(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease","volume":"42","author":"Harada","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R111-11-20210129","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: A Novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","author":"Harada","year":"2016","journal-title":"J Nucl Med"},{"key":"R112-11-20210129","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","article-title":"Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls","volume":"79","author":"Maruyama","year":"2013","journal-title":"Neuron"},{"key":"R113-11-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807","volume":"34","author":"Chien","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"R114-11-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-130098","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808","volume":"38","author":"Chien","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"R115-11-20210129","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"key":"R116-11-20210129","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neurobiolaging.2014.12.002","article-title":"Isolation and characterization of antibody fragments selective for toxic oligomeric tau","volume":"36","author":"Tian","year":"2015","journal-title":"Neurobiol Aging"},{"key":"R117-11-20210129","doi-asserted-by":"crossref","first-page":"16835","DOI":"10.1523\/JNEUROSCI.2755-14.2014","article-title":"Antibody-derived in vivo imaging of tau pathology","volume":"34","author":"Krishnaswamy","year":"2014","journal-title":"J Neurosci"},{"key":"R118-11-20210129","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: A randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"R119-11-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer's disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"R120-11-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/cn5000309","article-title":"Neuroprotective effects of lithium: Implications for the treatment of Alzheimer's disease and related neurodegenerative disorders","volume":"5","author":"Forlenza","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"R121-11-20210129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","volume":"68","author":"Tariot","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R122-11-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-016-0082-7","article-title":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy","volume":"11","author":"Barini","year":"2016","journal-title":"Mol Neurodegener"},{"key":"R124-11-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","article-title":"Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: A randomised, double-blind, placebo-controlled, phase 1 trial","volume":"16","author":"Novak","year":"2017","journal-title":"Lancet Neurol"},{"key":"R125-11-20210129","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jalz.2015.06.1884","article-title":"A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease","volume":"11","author":"Agadjanyan","year":"2015","journal-title":"Alzheimers Dement"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.220313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:45:33Z","timestamp":1623959133000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201712200-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":122,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.220313","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,20]]}}}